Cerba Healthcare to Acquire Viroclinics to Strengthen Position in Value Chain of Diagnosis.

MANews-(C)2009-2021

French medical diagnosis company Cerba HealthCare has agreed to acquire Netherlands-based virology and immunology contract research organisation (CRO) Viroclinics-DDL from Summit Partners to strengthen its position in the entire value chain of diagnosis, the company said.

The transaction is subject to regulatory approvals and customary conditions, such as completion of the consultation procedure with Central Works Council of Viroclinics-DDL. The acquisition is expected to close by end of 1Q22.

Terms were not disclosed.

Viroclinics-DDL, employing a total of over 390 scientists and experts, offers a broad range of virology related services in the field of non-clinical and clinical trials, clinical diagnostics, assay development and clinical trial logistics enabling the development of antiviral drugs, vaccines, and other therapies.

The acquisition fits perfectly into Cerba HealthCare's strategy aimed at further strengthening its position in the entire diagnostic and clinical trial laboratory services value chain, while...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT